Ourania Tatsis insider trades: Vertex Pharmaceuticals Inc / Ma (VRTX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ourania reports to the SEC
Open-market buys and sales
39 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | VRTX | ↓ Sell | 1,500 | $524.99 | $787K | Direct | Jul 7, 2026 (5d) |
| Feb 25, 2026 | VRTX | ↓ Sell | 260 | $486.35 | $126K | Direct | Feb 26, 2026 (1d) |
| Feb 18, 2026 | VRTX | ↓ Sell | 977 | $483.52 | $472K | Direct | Feb 19, 2026 (1d) |
| Feb 13, 2026 | VRTX | ↓ Sell | 1,500 | $499.99 | $750K | Direct | Feb 18, 2026 (5d) |
| Feb 11, 2026 | VRTX | ↓ Sell | 466 | $460.43 | $215K | Direct | Feb 12, 2026 (1d) |
| Jan 7, 2026 | VRTX | ↓ Sell | 4,500 | $474.99 | $2.1M | Direct | Jan 9, 2026 (2d) |
| Dec 3, 2025 | VRTX | ↓ Sell | 4,500 | $449.99 | $2.0M | Direct | Dec 5, 2025 (2d) |
| Mar 10, 2025 | VRTX | ↓ Sell | 3,242 | $499.99 | $1.6M | Direct | Mar 12, 2025 (2d) |
| Mar 4, 2025 | VRTX | ↓ Sell | 4,058 | $485.49 | $2.0M | Direct | Mar 6, 2025 (2d) |
| Feb 27, 2025 | VRTX | ↓ Sell | 530 | $475.34 | $252K | Direct | Feb 28, 2025 (1d) |
| Feb 25, 2025 | VRTX | ↓ Sell | 354 | $480.95 | $170K | Direct | Feb 26, 2025 (1d) |
| Feb 18, 2025 | VRTX | ↓ Sell | 244 | $455.06 | $111K | Direct | Feb 19, 2025 (1d) |
| Feb 11, 2025 | VRTX | ↓ Sell | 310 | $459.83 | $143K | Direct | Feb 12, 2025 (1d) |
| Jun 3, 2024 | VRTX | ↓ Sell | 2,175 | $460.00 | $1.0M | Direct | Jun 5, 2024 (2d) |
| May 31, 2024 | VRTX | ↓ Sell | 4,600 | $441.99 | $2.0M | Direct | Jun 3, 2024 (3d) |
| Feb 26, 2024 | VRTX | ↓ Sell | 354 | $425.70 | $151K | Direct | Feb 27, 2024 (1d) |
| Feb 21, 2024 | VRTX | ↓ Sell | 360 | $421.77 | $152K | Direct | Feb 23, 2024 (2d) |
| Feb 20, 2024 | VRTX | ↓ Sell | 480 | $420.79 | $202K | Direct | Feb 21, 2024 (1d) |
| Feb 12, 2024 | VRTX | ↓ Sell | 314 | $420.24 | $132K | Direct | Feb 13, 2024 (1d) |
| Aug 23, 2023 | VRTX | ↓ Sell | 2,500 | $355.00 | $888K | Direct | Aug 25, 2023 (2d) |
| Aug 10, 2023 | VRTX | ↓ Sell | 5,750 | $345.79 | $2.0M | Direct | Aug 14, 2023 (4d) |
| Feb 27, 2023 | VRTX | ↓ Sell | 354 | $287.48 | $102K | Direct | Feb 28, 2023 (1d) |
| Feb 21, 2023 | VRTX | ↓ Sell | 480 | $293.75 | $141K | Direct | Feb 22, 2023 (1d) |
| Feb 14, 2023 | VRTX | ↓ Sell | 320 | $298.52 | $96K | Direct | Feb 16, 2023 (2d) |
| Feb 13, 2023 | VRTX | ↓ Sell | 275 | $298.99 | $82K | Direct | Feb 14, 2023 (1d) |
| Aug 9, 2022 | VRTX | ↓ Sell | 1,400 | $298.97 | $419K | Direct | Aug 10, 2022 (1d) |
| Mar 17, 2022 | VRTX | ↓ Sell | 2,833 | $250.11 | $709K | Direct | Mar 21, 2022 (4d) |
| Feb 25, 2022 | VRTX | ↓ Sell | 325 | $230.95 | $75K | Direct | Feb 28, 2022 (3d) |
| Feb 18, 2022 | VRTX | ↓ Sell | 519 | $231.00 | $120K | Direct | Feb 22, 2022 (4d) |
| Feb 11, 2022 | VRTX | ↓ Sell | 290 | $235.09 | $68K | Direct | Feb 14, 2022 (3d) |
| May 15, 2020 | VRTX | ↓ Sell | 120 | $284.00 | $34K | Direct | May 19, 2020 (4d) |
| May 6, 2020 | VRTX | ↓ Sell | 966 | $272.70 | $263K | Direct | May 8, 2020 (2d) |
| Feb 25, 2020 | VRTX | ↓ Sell | 1,296 | $233.17 | $302K | Direct | Feb 26, 2020 (1d) |
| Feb 18, 2020 | VRTX | ↓ Sell | 1,279 | $243.62 | $312K | Direct | Feb 19, 2020 (1d) |
| Feb 6, 2020 | VRTX | ↓ Sell | 967 | $239.43 | $232K | Direct | Feb 7, 2020 (1d) |
| Jan 8, 2020 | VRTX | ↓ Sell | 1,675 | $227.53 | $381K | Direct | Jan 10, 2020 (2d) |
| Nov 15, 2019 | VRTX | ↓ Sell | 5 | $205.95 | $1K | Direct | Nov 19, 2019 (4d) |
| Nov 13, 2019 | VRTX | ↓ Sell | 2,853 | $205.59 | $587K | Direct | Nov 15, 2019 (2d) |
| Oct 2, 2019 | VRTX | ↓ Sell | 632 | $168.11 | $106K | Direct | Oct 3, 2019 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other VRTX insiders
Open-market trades in the last 12 months
About Ourania Tatsis's insider trades
Ourania Tatsis is EVP, Chief Reg. & Quality Off. at Vertex Pharmaceuticals Inc / Ma (VRTX). Since Oct 2, 2019, Ourania has reported no open-market purchases and 39 sales worth $21.4M on SEC Form 4. In the last 12 months: 7 sales ($6.5M).
Their filings also include shares withheld for taxes (22 filings), grants and awards (12 filings), option exercises (4 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VRTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.